Photo: Kristoffer Tripplaar/Sipa USA/Sipa via AP Images
December 20, 2022 03:57 PM ESTUpdated December 21, 02:42 PM
Pharma
Manufacturing

Up­dat­ed: Sev­er­al man­u­fac­tur­ers re­port Tam­i­flu short­age as flu sea­son reach­es high point

Tyler Patchen

News Reporter

As the flu sea­son con­tin­ues to rage, with the CDC re­port­ing over 23,000 hos­pi­tal­iza­tions for in­fluen­za, sev­er­al man­u­fac­tur­ers have re­port­ed short­ages …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times